Wang Xin Shelley, Woodruff Jeanie F
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gynecol Oncol. 2015 Mar;136(3):446-52. doi: 10.1016/j.ygyno.2014.10.013. Epub 2014 Oct 23.
Fatigue is a distressing and persistent symptom for patients with gynecological cancer and for survivors. Debilitating cancer-related fatigue (CRF) is produced by both the disease and its treatment. Although awareness and study of CRF have grown in recent years, consistent assessment has not been a priority in routine medical practice. The pathophysiological mechanisms that induce CRF remain unclear, and effective pharmacological interventions have yet to be established. Based on the literature and our own research results, this review focuses on recent progress toward understanding the nature and causes of CRF and on several promising treatment modalities. Given the prevalence and severity of CRF in the gynecological cancer patient population, establishing standardized fatigue measurement and management methods in routine clinical oncology care is of utmost importance. Whether CRF has an underlying inflammatory cause is still hypothetical, however, and no mechanism-driven symptom intervention is currently in clinical use, even though the development of such interventions would provide patients with greater symptom control. Advancing translational and clinical fatigue research will require anatomical pathway studies and well-designed clinical investigations that focus on the development of mechanism-driven interventions based on physiological-behavioral fatigue research, implementation of guidelines for experimental designs, and discovery of biomarkers identifying individuals at high risk for CRF. Validated patient-reported outcomes measures are an essential component of such clinical studies. Because numerous subscales, unidimensional measures, and multidimensional measures exist, clinicians and researchers should consider individual circumstances, good clinical practice, and research goals as guides for choosing the most appropriate fatigue measurement tool. Additionally, education about CRF should be made available to all patients and their caregivers, as accurate and age-appropriate information about conditions like CRF can alleviate much of the stress and anxiety brought on by poor communication about this distressing condition.
疲劳是妇科癌症患者及其幸存者令人苦恼且持续存在的症状。与癌症相关的使人虚弱的疲劳(CRF)是由疾病及其治疗共同导致的。尽管近年来对CRF的认识和研究有所增加,但在常规医疗实践中,持续评估并非优先事项。诱发CRF的病理生理机制仍不清楚,有效的药物干预措施尚未确立。基于文献和我们自己的研究结果,本综述重点关注在理解CRF的性质和原因方面的最新进展以及几种有前景的治疗方式。鉴于CRF在妇科癌症患者群体中的普遍性和严重性,在常规临床肿瘤护理中建立标准化的疲劳测量和管理方法至关重要。然而,CRF是否有潜在的炎症原因仍只是一种假设,目前尚无基于机制的症状干预措施应用于临床,尽管开发此类干预措施将为患者提供更好的症状控制。推进转化和临床疲劳研究将需要进行解剖学通路研究以及精心设计的临床调查,这些研究应专注于基于生理行为疲劳研究开发基于机制的干预措施、实施实验设计指南以及发现识别CRF高风险个体的生物标志物。经过验证的患者报告结局测量是此类临床研究的重要组成部分。由于存在众多子量表、单维测量方法和多维测量方法,临床医生和研究人员应考虑个体情况、良好的临床实践和研究目标,以此作为选择最合适疲劳测量工具的指南。此外,应向所有患者及其护理人员提供有关CRF的教育,因为关于CRF等病症的准确且适合年龄的信息可以减轻因对此令人苦恼的病症沟通不畅而带来的许多压力和焦虑。